KathrynAnnMortonMD

Professor, Radiology, University of Utah School of Medicine

Dr. Morton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
50 N Medical Dr
Salt Lake City, UT 84132
Phone+1 801-581-2121

Fax+1 801-584-1289

University of Utah HealthResidency, Radiology-Diagnostic, 1984 - 1987
University of Utah HealthResidency, Nuclear Medicine, 1983 - 1984
University of North Carolina HospitalsInternship, Transitional Year, 1982 - 1983
University of Utah School of MedicineClass of 1982

OR State Medical License 1995 - Present
NH State Medical License 2024 - 2026
UT State Medical License 1984 - 2026
ID State Medical License 2022 - 2025
NC State Medical License 1982 - 2025
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology with Special Competence in Nuclear Radiology

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

PubMed

9 citations
Prospective Pilot Study ofF-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas.
Matthew F Covington, John M Hoffman, Kathryn A Morton, Brandon Buckway, Kenneth M Boucher
AJR. American Journal of Roentgenology. 2023-08-01
9 citations
PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies.
Ahmed Ebada Salem, Harsh R Shah, Matthew F Covington, Bhasker R Koppula, Gabriel C Fine
Cancers. 2022-11-30
11 citations
PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.
Ahmed Ebada Salem, Gabriel C Fine, Matthew F Covington, Bhasker R Koppula, Richard H Wiggins
Cancers. 2022-06-18

FDG PET In Cancer-Associated Venothromboembolic DiseaseNational Cancer Institute2006–2009
Core--ImagingNational Institute On Drug Abuse2007–2008
Imaging Phenotypes In Copper Metabolism Disease In MiceNational Institute Of Biomedical Imaging And Bioengineering2006–2007
Tumor Uptake Of Ga-67 By Photodegraded NifedipineNational Cancer Institute2004
Tumor Uptake Of Ga-67 By Photodegraded NifedipineNational Cancer Institute2002–2003
Technical And Applied SciencesCenter For Scientific Review2000–2002
Tumor Uptake Of Ga67 By Photodegraded NifedipineNational Cancer Institute2001
Tumor Uptake Of Ga67 By Photodegraded NifedipineNational Cancer Institute1999–2000
Tumor Imaging With Nuclides That Bind To MetallothioneinNational Cancer Institute1989–1993